TiA1 in advanced-stage classical Hodgkin’s lymphoma: no prognostic impact for positive tumour cells or number of cytotoxic cells

By Camilleri-Broët Sophie  

Virchows Archiv, Vol. 445, Iss. 4, 2004-10 ,pp. : 344-346

Springer Publishing Company

Access to resources Recommend Favorite

Hodgkin’s lymphoma in a patient with Jo-1 syndrome

By Adam Alexander   Grohé Christian   Stier Sebastian   Gattenlöhner Stefan   Balta Zeynep   Büttner Reinhard   Gütgemann Ines  

Virchows Archiv, Vol. 451, Iss. 1, 2007-07 ,pp. : 101-104

Springer Publishing Company

Access to resources Recommend Favorite

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma

By Ianni Mauro Di   Ballanti Stelvio   Iodice Giuseppe   Reale Antonia   Falzetti Franca   Minelli Olivia   Serio Gabriella   Martelli Massimo F   Dammacco Franco   Vacca Angelo   Ria Roberto  

Hematology, Vol. 17, Iss. 1, 2012-01 ,pp. : 23-27

Maney Publishing

Access to resources Recommend Favorite

Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients

By Singh R.K.   Varney M.L.   Ino K.   Vose J.M.   Bierman P.J.   Talmadge J.E.  

Experimental Hematology, Vol. 28, Iss. 5, 2000-05 ,pp. : 499-507

Elsevier

Access to resources Recommend Favorite

BLyS and BLyS receptor expression in non-Hodgkin's lymphoma

By Briones J.   Timmerman J.M.   Hilbert D.M.   Levy R.  

Experimental Hematology, Vol. 30, Iss. 2, 2002-02 ,pp. : 135-141

Elsevier

Access to resources Recommend Favorite